Chiron Expects Full Fluvirin Vaccine Production In 2006-2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Fluvirin flu vaccine production capacity for 2005-2006 will be lower than the previous estimate of 18 mil.-25 mil. doses due to a shortened production season, CEO Pien says.
You may also be interested in...
Chiron’s Adjuvant Could Quadruple Flu Vaccine Capacity, CEO Pien Says
The firm will meet with FDA to determine the regulatory pathway for the MF59 adjuvant in 2006.
Chiron’s Adjuvant Could Quadruple Flu Vaccine Capacity, CEO Pien Says
The firm will meet with FDA to determine the regulatory pathway for the MF59 adjuvant in 2006.
Chiron Inks $62.5 Mil. Avian Flu Vaccine Deal With HHS
HHS Secretary Leavitt looks to cell culture-based technology for more rapid vaccine production in case of future pandemics.